The window for intervention may be wider than anyone realized
A Finnish longitudinal study quietly repositions fatty liver disease from an adult condition shaped by personal choices to one whose roots reach into the womb and the earliest years of life. Researchers following nearly 500 children from infancy through adolescence found that a mother's blood pressure before pregnancy, the way an infant is fed, and the dietary patterns of early childhood all leave measurable traces on the liver years later. The findings do not yet establish cause, but they widen the window of prevention in a way that invites medicine to look backward — toward pregnancy itself — rather than waiting for disease to announce itself in adulthood.
- A mother's pre-pregnancy hypertension was linked to elevated liver stress markers in her children not just in early childhood but persistently into the teenage years, suggesting the prenatal environment shapes metabolic destiny in ways still poorly understood.
- Children carrying visceral fat — the kind stored deep around the organs — showed higher liver enzyme levels from an early age, confirming that where the body stores fat matters as much as how much it stores.
- Shorter breastfeeding, earlier introduction of solid foods, and diets heavy in animal-based products and dairy were each associated with higher liver markers, while fruits, vegetables, and berries appeared protective.
- Notably absent from the risk picture: exercise, physical fitness, and sleep — factors long assumed central to metabolic health showed no meaningful connection to liver disease indicators in this cohort.
- Roughly 12 to 15 percent of otherwise healthy children showed elevated ALT levels — a subclinical warning sign that may quietly precede metabolic syndrome and liver disease decades before a diagnosis is made.
- Researchers are calling for validation across other populations before firm conclusions are drawn, but the study's arc points toward a striking possibility: that preventing fatty liver disease may require intervening before a child is even born.
Fatty liver disease has long been framed as a condition of adult habits and inherited genes — something that accumulates over decades of choices. A new Finnish study challenges that framing, tracing the disease's earliest signals back to the months before birth and the first years of life.
Researchers at Tampere University and the University of Eastern Finland followed 488 children from early childhood through adolescence, measuring a liver enzyme called ALT — a marker that rises when the liver is under stress — alongside their mothers' prenatal health, their own body composition, and their dietary patterns. The study, published in The Journal of Pediatrics, was searching for early indicators of metabolic dysfunction-associated steatotic liver disease, the condition formerly known as fatty liver disease.
The most striking finding involved maternal health: mothers with high blood pressure before pregnancy were more likely to have children with elevated ALT levels, and that association persisted into adolescence. Lead researcher Hanna de Ruyter acknowledged that causation remains unproven, but the pattern suggests a mother's cardiometabolic health during pregnancy may shape her child's liver function in lasting ways.
The child's own body composition also mattered — specifically visceral fat, the kind stored deep around the organs, which was linked to higher liver markers from early childhood onward. Diet told a similarly clear story: shorter breastfeeding, earlier introduction of solid foods, and heavier consumption of animal-based products and dairy were each associated with elevated ALT levels, while fruits, vegetables, and berries appeared protective. Physical activity, fitness, and sleep, by contrast, showed no meaningful connection to liver disease risk in this group.
Most children in the study were healthy, and actual fatty liver disease was uncommon. But 12 to 15 percent showed elevated ALT — a subclinical signal that can precede serious metabolic disease later in life. Professor Kalle Kurppa noted that the findings, once validated in other populations, could open a wider window for prevention than previously imagined — one that stretches back to pregnancy itself.
Fatty liver disease has long been understood as a problem of inheritance and adult choices—what you eat, how much you move, what your parents passed down in their genes. But a new study from Finnish researchers suggests the story begins much earlier, in the months before a child is even born, and continues through the first years of life in ways that shape liver health well into the teenage years.
Researchers at Tampere University and the University of Eastern Finland followed 488 Finnish children from early childhood through adolescence, tracking their mothers' health during pregnancy alongside their own diet, body composition, and metabolic markers. They were looking for early signs of metabolic dysfunction-associated steatotic liver disease, or MASLD—the medical term for what used to be called fatty liver disease. The specific marker they measured was alanine aminotransferase, or ALT, an enzyme that rises when the liver is under stress. The results, published in The Journal of Pediatrics, paint a picture of how far back the roots of this disease actually go.
One finding stood out: mothers who had high blood pressure before pregnancy were more likely to have children with elevated ALT levels, not just in childhood but continuing into adolescence. This suggests that a mother's cardiometabolic health during the prenatal period—her heart and metabolic function—may directly influence whether her child develops signs of liver disease years later. Hanna de Ruyter, the doctoral researcher who led the study, was careful to note that while the association is clear, proving that one causes the other will require more research. But the pattern is striking enough to suggest that maternal health matters in ways we're only beginning to understand.
The child's own body composition emerged as another strong predictor. Visceral adiposity—fat stored deep in the abdomen around the organs—was linked to higher ALT levels from early childhood onward. This aligns with what scientists already suspected: the type of fat a child carries matters more than the amount.
Then there was the question of how children were fed. Babies who were breastfed for shorter periods and introduced to solid foods earlier showed higher ALT levels by adolescence. But the most striking dietary finding involved what children ate as they grew older. A diet heavy in animal-based foods and dairy products was associated with elevated liver markers, particularly in later childhood and the teenage years. By contrast, children who ate more fruits, vegetables, and berries showed lower ALT levels. These dietary patterns held up when researchers looked at the children's metabolic biomarkers, suggesting the effect was real and measurable.
Interestingly, the study found no meaningful connection between ALT levels and how much children exercised, how fit they were, or how well they slept. Physical activity and sleep matter for health in many ways, but they didn't predict liver disease risk in this cohort.
The researchers emphasized that most children in the study were healthy and actual fatty liver disease was uncommon. But about 12 to 15 percent showed elevated ALT levels—a warning sign that matters because it can precede metabolic syndrome and liver disease later in life. Professor Kalle Kurppa noted that while these findings need to be tested in other populations before drawing firm conclusions, they point toward something important: the possibility of preventing liver disease by addressing risk factors early, before the disease ever takes hold. The window for intervention may be wider than anyone realized—stretching back to pregnancy itself.
Notable Quotes
Maternal cardiometabolic health in the prenatal period may contribute significantly to the development of MASLD in the offspring, though further studies are required to establish causation.— Hanna de Ruyter, lead researcher, Tampere University
The study provides important new insights into the early-life origins of MASLD and may contribute to preventive strategies addressing risk factors before liver disease onset.— Professor Kalle Kurppa, Tampere University
The Hearth Conversation Another angle on the story
Why does a mother's blood pressure during pregnancy matter for her child's liver fifteen years later? That seems like a long chain of causation.
It does seem distant, but the prenatal environment shapes how a child's metabolism develops from the start. High blood pressure signals that the mother's cardiovascular and metabolic systems are stressed. That stress can influence how the fetus develops, potentially making the child's liver more vulnerable to fat accumulation later.
But you said the researchers were careful not to claim causation. What's the difference between association and cause?
Association means we see them together—mothers with hypertension have children with higher liver markers. Cause would mean the hypertension directly produces that outcome. To prove cause, you'd need to show the mechanism, rule out other explanations, and ideally see it happen the same way in different populations. They have the first part; they need the rest.
So the diet findings—high animal foods, low vegetables—that's clearer?
It's more intuitive, yes. We know animal-based foods are often higher in saturated fat and cholesterol, things that stress the liver. Vegetables and fruits have protective compounds. But even there, the study shows association. The mechanism is plausible, but it's not proven.
What strikes you most about this?
That 12 to 15 percent of healthy children already show warning signs. These aren't sick kids. They're normal. But their livers are already signaling trouble. That's the moment to intervene—before disease takes hold.
And that's possible? Can you reverse elevated ALT in a child?
That's the question the next studies need to answer. If you change a child's diet, shorten their time with animal foods, increase vegetables—does the liver recover? We don't know yet. But this study suggests the window to try is open.